Search

The CityView Newsletter is a biannual publication of the City of Cambridge Public Information Office that is mailed to residential households in May and November. The newsletter includes a variety of updates and brief overviews on City programs and services. The spring-summer edition generally highlights key City initiatives for the coming fiscal year.

Movie: War Horse The story follows a young man named Albert and his horse, Joey, who is sold to the cavalry at the outbreak of World War I.

On Tuesday, November 18 from 5:30 p.m. to 8 p.m., the Cambridge Department of Transportation will host the fifth Working Group Meeting for the Broadway Safety Improvement Project.

City of Cambridge page dedicated to projects illuminating the history and presence of Native Peoples in Cambridge, starting with the Indigenous language street signs in the East Cambridge neighborhood.

Join us on Wednesday, July 15 from 5-7 p.m. at Danehy Park (Sherman Street entrance) as we celebrate the completion of the City's Danehy Park Improvement Plan. There will be face painting, treats and more! The plan is a shared vision of the future of Danehy Park that guides improvements for the next 10-15 years.

Meeting minutes of the Family Policy Council meeting held January 18th, 2018

The health and safety of the Cambridge community is our top priority during this unprecedented time. While many of the city’s food pantries have temporarily closed, we are working to ensure that Cambridge residents have access to food during the COVID-19 outbreak.

Join City staff and the project team to review the concepts and share your feedback.

A project page for the Wellington-Harrington Action Plan. Part of the Neighborhood Planning Initiative.

Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.